Utah Retirement Systems’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,018
Closed -$571K 956
2020
Q4
$571K Buy
1,018
+46
+5% +$29.2K 0.01% 816
2020
Q3
$679K Buy
972
+23
+2% +$17.9K 0.01% 779
2020
Q2
$750K Buy
949
+139
+17% +$105K 0.01% 736
2020
Q1
$483K Hold
810
0.01% 783
2019
Q4
$921K Buy
810
+8
+1% +$8.7K 0.02% 755
2019
Q3
$954K Hold
802
0.02% 729
2019
Q2
$1.32M Buy
802
+13
+2% +$22.5K 0.03% 622
2019
Q1
$1.61M Buy
789
+9
+1% +$15.8K 0.03% 534
2018
Q4
$1M Hold
780
0.02% 645
2018
Q3
$1.48M Buy
780
+62
+9% +$128K 0.03% 581
2018
Q2
$1.46M Buy
+718
New +$1.64M 0.03% 562
2016
Q2
Sell
-494
Closed -$272K 998
2016
Q1
$272K Hold
494
0.01% 959
2015
Q4
$411K Hold
494
0.01% 902
2015
Q3
$548K Buy
494
+39
+9% +$71.1K 0.02% 833
2015
Q2
$994K Buy
+455
New +$927K 0.03% 648

Other funds holding BLUE

Utah Retirement Systems's BLUE Position: Q1 2021 in Review

Utah Retirement Systems sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 1,018 shares — an estimated $571K sold.

Utah Retirement Systems first reported a position in BLUE in Q2 2015 and held it in 15 quarters. The position peaked at $1.61M in Q1 2019. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Utah Retirement Systems reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Utah Retirement Systems sold 1,018 bluebird bio shares in Q1 2021, an estimated $571K.
  • Utah Retirement Systems first reported a position in bluebird bio in Q2 2015 and held it in 15 quarters.
  • Utah Retirement Systems's bluebird bio position peaked at $1.61M in Q1 2019.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Utah Retirement Systems's 13F filing for Q1 2021, filed 17 May 2021.